Skip to main content
. 2013 Feb 8;2:42. doi: 10.1186/2193-1801-2-42

Table 3.

HLA-B single amino acid polymorphisms**

Positions Amino acid Patients (176) n (%) Controls (329) n (%) Odds Ratio Pu value* Pc value*
9 D 29(16.48) 52(15.81) 1.0 0.84 NS
9 H 57(32.39) 118(35.87) 0.9 0.43 NS
11 A 154(87.50) 303(92.10) 1.0 0.09 NS
11 S 85(48.30) 174(52.89) 0.9 0.33 NS
12 M 149(84.66) 298(90.58) 0.9 0.05 NS
12 V 95(53.98) 187(56.84) 0.9 0.54 NS
24 A 92(52.27) 172(52.28) 1.0 1.00 NS
24 S 110(62.50) 205(62.31) 1.0 0.97 NS
24 T 88(50.00) 173(52.58) 1.0 0.58 NS
32 L 79(44.89) 162(49.24) 0.9 0.35 NS
41 T 80(45.45) 157(47.72) 1.0 0.63 NS
45 E 115(65.34) 210(63.83) 1.0 0.74 NS
45 K 72(40.91) 147(44.68) 0.9 0.42 NS
45 M 43(24.43) 83(25.23) 1.0 0.84 NS
45 T 71(40.34) 137(41.64) 1.0 0.78 NS
46 A 43(24.43) 83(25.23) 1.0 0.84 NS
62 G 19(10.80) 37(11.25) 1.0 0.88 NS
63 E 122(69.32) 245(74.47) 0.9 0.22 NS
63 N 136(77.27) 269(81.76) 0.9 0.23 NS
65 R 22(12.50) 40(12.16) 1.0 0.91 NS
66 N 22(12.50) 40(12.16) 1.0 0.91 NS
67 C 49(27.84) 78(23.71) 1.2 0.31 NS
67 F 68(38.64) 139(42.25) 0.9 0.43 NS
67 M 22(12.50) 40(12.16) 1.0 0.91 NS
67 S 110(62.50) 215(65.35) 1.0 0.52 NS
67 Y 56(31.82) 97(29.48) 1.1 0.59 NS
69 A 75(42.61) 144(43.77) 1.0 0.80 NS
70 Q 55(31.25) 96(29.18) 1.1 0.63 NS
70 S 22(12.50) 40(12.16) 1.0 0.91 NS
71 A 78(44.32) 146(44.38) 1.0 0.99 NS
74 D 107(60.80) 193(58.66) 1.0 0.64 NS
74 Y 151(85.80) 291(88.45) 1.0 0.39 NS
77 N 94(53.41) 183(55.62) 1.0 0.63 NS
77 S 155(88.07) 276(83.89) 1.0 0.21 NS
80 I 50(28.41) 106(32.22) 0.9 0.38 NS
80 N 154(87.50) 277(84.19) 1.0 0.32 NS
80 T 66(37.50) 118(35.87) 1.0 0.72 NS
81 A 94(53.41) 183(55.62) 1.0 0.63 NS
81 L 158(89.77) 290(88.15) 1.0 0.58 NS
82 L 104(59.09) 197(59.88) 1.0 0.86 NS
82 R 154(87.50) 277(84.19) 1.0 0.32 NS
83 G 154(87.50) 277(84.19) 1.0 0.32 NS
83 R 104(59.09) 197(59.88) 1.0 0.86 NS
94 I 85(48.30) 163(49.54) 1.0 0.79 NS
95 I 91(51.70) 166(50.46) 1.0 0.79 NS
95 L 143(81.25) 256(77.81) 1.0 0.37 NS
95 W 49(27.84) 106(32.22) 0.9 0.31 NS
97 R 139(78.98) 245(74.47) 1.1 0.26 NS
97 S 80(45.45) 145(44.07) 1.0 0.77 NS
97 T 35(19.89) 83(25.23) 0.8 0.18 NS
97 W 24(13.64) 23(6.99) 2.0 0.01 NS
103 L 70(39.77) 103(31.31) 1.3 0.06 NS
113 Y 85(48.30) 147(44.68) 1.1 0.44 NS
114 D 133(75.57) 241(73.25) 1.0 0.57 NS
114 N 122(69.32) 227(69.00) 1.0 0.94 NS
116 D 52(29.55) 103(31.31) 0.9 0.68 NS
116 F 47(26.70) 67(20.36) 1.3 0.10 NS
116 L 28(15.91) 48(14.59) 1.1 0.69 NS
116 S 72(40.91) 135(41.03) 1.0 0.98 NS
116 Y 108(61.36) 221(67.17) 0.9 0.19 NS
131 R 89(50.57) 173(52.58) 1.0 0.67 NS
131 S 158(89.77) 299(90.88) 1.0 0.69 NS
143 S 14(7.95) 37(11.25) 0.7 0.24 NS
147 L 14(7.95) 37(11.25) 0.7 0.24 NS
152 E 108(61.36) 188(57.14) 1.1 0.36 NS
152 V 155(88.07) 281(85.41) 1.0 0.41 NS
156 D 63(35.80) 111(33.74) 1.1 0.64 NS
156 L 148(84.09) 275(83.59) 1.0 0.88 NS
156 R 40(22.73) 80(24.32) 0.9 0.69 NS
156 W 24(13.64) 37(11.25) 1.2 0.43 NS
158 T 17(9.66) 33(10.03) 1.0 0.89 NS
163 E 71(40.34) 149(45.29) 0.9 0.29 NS
163 L 123(69.89) 248(75.38) 0.9 0.18 NS
163 T 87(49.43) 148(44.98) 1.1 0.34 NS
167 S 46(26.14) 87(26.44) 1.0 0.94 NS
171 H 46(26.14) 93(28.27) 0.9 0.61 NS
177 D 81(46.02) 162(49.24) 0.9 0.49 NS
178 K 50(28.41) 109(33.13) 0.9 0.28 NS
180 E 81(46.02) 162(49.24) 0.9 0.49 NS

*Pu, uncorrected P values; Pc, corrected P values.

† Polymorphic amino acid positions 3, 9, 12, 14, 17, 19, 31, 35, 43, 44, 56, 62, 63, 65, 66, 67, 70, 73, 74, 76, 77, 79, 80, 81, 82, 83, 90, 95, 97, 99, 102, 105, 107, 109, 114, 116, 127, 142, 144, 149, 150, 151, 152, 156, 158, 161, 163, 166, 167, 171.

** Not displaying amino acid residues that were present in 90% or greater in both patient and

control groups, or were present in 10% or fewer in both patient and control groups.